Mayne Pharma unit Myx settles US Imvexxy patent case with Sun Pharma, entry set 21 Oct 2032

Myx settled US patent litigation regarding Imvexxy with Sun Pharma. The generic Imvexxy market entry date is set for 21 October 2032; settlement does not include financial payment or upfront monetary consideration.